Whats new
Whats new.
Maxim Group - Efti in 1L Lung Cancer at SITC – Response Rates are Favorable, but it's the Duration of Response that Impresses (Analyst: Jason McCarthy)
November 10th 2022
For a copy of this analyst report please contact your Maxim analyst Jason McCarthy - jmccarthy@maximgrp.com